Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Valvular Heart Disease

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 6 articles:
HTML format
Text format



Single Articles


    August 2015
  1. LACEY D, Hickey P, Arhatari BD, O'Reilly LA, et al
    Spontaneous retrotransposon insertion into TNF 3'UTR causes heart valve disease and chronic polyarthritis.
    Proc Natl Acad Sci U S A. 2015;112:9698-703.
    PubMed     Text format     Abstract available


    July 2015
  2. GRANZIER HL, de Tombe PP
    Myosin light chain phosphorylation to the rescue.
    Proc Natl Acad Sci U S A. 2015;112:9148-9.
    PubMed     Text format    


  3. YUAN CC, Muthu P, Kazmierczak K, Liang J, et al
    Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
    Proc Natl Acad Sci U S A. 2015;112:E4138-46.
    PubMed     Text format     Abstract available


    March 2015
  4. NOTARI M, Hu Y, Sutendra G, Dedeic Z, et al
    iASPP, a previously unidentified regulator of desmosomes, prevents arrhythmogenic right ventricular cardiomyopathy (ARVC)-induced sudden death.
    Proc Natl Acad Sci U S A. 2015;112:E973-81.
    PubMed     Text format     Abstract available


    November 2014
  5. FU Y, Westenbroek RE, Scheuer T, Catterall WA, et al
    Basal and beta-adrenergic regulation of the cardiac calcium channel CaV1.2 requires phosphorylation of serine 1700.
    Proc Natl Acad Sci U S A. 2014;111:16598-603.
    PubMed     Text format     Abstract available


    October 2014
  6. TAJAN M, Batut A, Cadoudal T, Deleruyelle S, et al
    LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesity.
    Proc Natl Acad Sci U S A. 2014 Oct 6. pii: 201406107.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: